|
1
|
Kiyan Y, Limbourg A, Kiyan R, et al:
Urokinase receptor associates with myocardin to control vascular
smooth muscle cells phenotype in vascular disease. Arterioscler
Thromb Vasc Biol. 32:110–122. 2012. View Article : Google Scholar
|
|
2
|
Matsuzawa Y, Funahashi T and Nakamura T:
Molecular mechanism of metabolic syndrome X: contribution of
adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad
Sci. 892:146–154. 1999. View Article : Google Scholar
|
|
3
|
Henry BA and Clarke IJ: Adipose tissue
hormones and the regulation of food intake. J Neuroendocrinol.
20:842–849. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamauchi T, Kamon J, Waki H, et al: The
fat-derived hormone adiponectin reverses insulin resistance
associated with both lipoatrophy and obesity. Nat Med. 7:941–946.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berg AH, Combs TP, Du X, Brownlee M and
Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic
insulin action. Nat Med. 7:947–953. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maeda N, Shimomura I, Kishida K, et al:
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.
Nat Med. 8:731–737. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsuzawa Y: Establishment of a concept of
visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad
Ser B Phys Biol Sci. 86:131–141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wulster-Radcliffe MC, Ajuwon KM, Wang J,
Christian JA and Spurlock ME: Adiponectin differentially regulates
cytokines in porcine macrophages. Biochem Biophys Res Commun.
316:924–929. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuda M, Shimomura I, Sata M, et al:
Role of adiponectin in preventing vascular stenosis The missing
link of adipo-vascular axis. J Biol Chem. 277:37487–37491. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen H, Montagnani M, Funahashi T,
Shimomura I and Quon MJ: Adiponectin stimulates production of
nitric oxide in vascular endothelial cells. J Biol Chem.
278:45021–45026. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maeda N, Shimomura I, Kishida K, et al:
Dietinduced insulin resistance in mice lacking adiponectin/ACRP30.
Nat Med. 8:731–737. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding M, Carrão AC, Wagner RJ, et al:
Vascular smooth muscle cell-derived adiponectin: a paracrine
regulator of contractile phenotype. J Mol Cell Cardiol. 52:474–484.
2012. View Article : Google Scholar :
|
|
13
|
Matsuda M, Shimomura I, Sata M, et al:
Role of adiponectin in preventing vascular stenosis. The missing
link of adipo-vascular axis. J Biol Chem. 277:37487–37491. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper
GJ and Xu A: Adiponectin inhibits cell proliferation by interacting
with several growth factors in an oligomerization-dependent manner.
J Biol Chem. 280:18341–18347. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Motobayashi Y, Izawa-Ishizawa Y, Ishizawa
K, et al: Adiponectin inhibits insulin-like growth factor-1-induced
cell migration by the suppression of extracellular signal-regulated
kinase 1/2 activation, but not Akt in vascular smooth muscle cells.
Hypertens Res. 32:188–193. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takaoka M, Nagata D, Kihara S, et al:
Periadventitial adipose tissue plays a critical role in vascular
remodeling. Circ Res. 105:906–911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miao CY and Li ZY: The role of
perivascular adipose tissue in vascular smooth muscle cell growth.
Br J Pharmacol. 165:643–658. 2012. View Article : Google Scholar :
|
|
18
|
Nepal S and Park PH: Regulatory role of
autophagy in globular adiponectin-induced apoptosis in cancer
cells. Biomol Ther (Seoul). 22:384–389. 2014. View Article : Google Scholar
|
|
19
|
Yamauchi T, Kamon J, Ito Y, et al: Cloning
of adiponectin receptors that mediate antidiabetic metabolic
effects. Nature. 423:762–769. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS
and Lodish HF: T-cadherin is a receptor for hexameric and
high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad
Sci USA. 101:10308–10313. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou L, Deepa SS, Etzler JC, et al:
Adiponectin activates AMP-activated protein kinase in muscle cells
via APPL1/LKB1-dependent and phospholipase
C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent
pathways. J Biol Chem. 284:22426–22435. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iwabu M, Yamauchi T, Okada-Iwabu M, et al:
Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca
(2+) and AMPK/SIRT1. Nature. 464:1313–1319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Santel A and Fuller MT: Control of
mitochondrial morphology by a human mitofusin. J Cell Sci.
114:867–874. 2001.PubMed/NCBI
|
|
24
|
Chen KH, Guo X, Ma D, et al: Dysregulation
of HSG triggers vascular proliferative disorders. Nat Cell Biol.
6:872–883. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin B, Fu G, Pan H, et al: Anti-tumour
efficacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol.
28(Suppl 1): 373–380. 2011. View Article : Google Scholar
|
|
26
|
Wu L, Li Z, Zhang Y, et al:
Adenovirus-expressed human hyper-plasia suppressor gene induces
apoptosis in cancer cells. Mol Cancer Ther. 7:222–232. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Zhu F, Wang S, et al: HSG provides
antitumor efficacy on hepatocellular carcinoma both in vitro and in
vivo. Oncol Rep. 24:183–188. 2010.PubMed/NCBI
|
|
28
|
Wang W, Lu J, Zhu F, et al: Pro-apoptotic
and anti-proliferative effects of mitofusin-2 via Bax signaling in
hepatocellular carcinoma cells. Med Oncol. 29:70–76. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen KH, Dasgupta A, Ding J, Indig FE,
Ghosh P and Longo DL: Role of mitofusin 2 (Mfn2) in controlling
cellular proliferation. FASEB J. 28:382–394. 2014. View Article : Google Scholar :
|
|
30
|
Zhang GE, Jin HL, Lin XK, Chen C, Liu XS,
Zhang Q and Yu JR: Anti-tumor effects of mfn2 in gastric cancer.
Int J Mol Sci. 14:13005–13021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ortmann J, Veit M, Zingg S, et al:
Estrogen receptor-α but not-β or GPER inhibits high glucose-induced
human VSMC proliferation: potential role of ROS and ERK. J Clin
Endocrinol Metab. 96:220–228. 2011. View Article : Google Scholar :
|
|
32
|
Sirois MG, Simons M and Edelman ER:
Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit
expression directs suppression of intimal thickening. Circulation.
95:669–676. 1997. View Article : Google Scholar : PubMed/NCBI
|
